查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1307472

體外診斷設備市場：按產品、最終用戶 - 俄羅斯-烏克蘭衝突、高通貨膨脹的累積影響 - 2023-2030 年全球預測

In-Vitro Diagnostics Instrument Market by Product, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球體外診斷設備市場預計到2023年將大幅成長，達到241.8億美元，年複合成長率為8.56%，預計到2030年將達到430.4億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球體外診斷器械市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球體外診斷設備市場規模及預測如何？

2.在預測期內，COVID-19對全球體外診斷設備市場的抑制要素和影響是什麼？

3.在預測期內，全球體外診斷設備市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球體外診斷設備市場的競爭策略是什麼？

5. 全球體外診斷器械市場的技術趨勢和法律規範是什麼？

6.全球體外診斷設備市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入體外診斷器械全球市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 老年人口增加，慢性病和感染疾病患病率顯著
      • 在已開發地區部署全自動化和 POC 設備並提高其可用性
      • 提高對疾病體徵和診斷的認知
    • 抑制因素
      • 不利的退款選擇
    • 機會
      • 有針對性的產品開發和商業化
      • 聯合研究/產品開發
    • 任務
      • 嚴格的法規要求
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 體外診斷設備市場：副產品

  • 臨床微生物學
  • 血液學
  • 止血
  • 免疫化學
  • 分子診斷
  • 注意事項
  • 血糖自我監測
  • 組織診斷

第7章 體外診斷設備市場：按最終用戶分類

  • 學術研究所
  • 家庭護理
  • 醫院和診斷實驗室

第8章 美洲體外診斷設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太體外診斷設備市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲體外診斷器械市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第12章上市公司名單

第13章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-43127F7279FC

The Global In-Vitro Diagnostics Instrument Market is forecasted to grow significantly, with a projected USD 24.18 billion in 2023 at a CAGR of 8.56% and expected to reach a staggering USD 43.04 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global In-Vitro Diagnostics Instrument Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global In-Vitro Diagnostics Instrument Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Clinical Microbiology, Hematology, Hemostasis, Immunochemistry, Molecular Diagnostics, Point-of-Care, Self-Monitoring of Blood Glucose, and Tissue Diagnostics. The Immunochemistry is projected to witness significant market share during forecast period.

Based on End User, market is studied across Academic & Research Institutes, Homecare, and Hospitals & Diagnostic Laboratories. The Hospitals & Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global In-Vitro Diagnostics Instrument Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global In-Vitro Diagnostics Instrument Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global In-Vitro Diagnostics Instrument Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global In-Vitro Diagnostics Instrument Market?

4. What is the competitive strategic window for opportunities in the Global In-Vitro Diagnostics Instrument Market?

5. What are the technology trends and regulatory frameworks in the Global In-Vitro Diagnostics Instrument Market?

6. What is the market share of the leading vendors in the Global In-Vitro Diagnostics Instrument Market?

7. What modes and strategic moves are considered suitable for entering the Global In-Vitro Diagnostics Instrument Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. In-Vitro Diagnostics Instrument Market, by Product, 2022 vs 2030
  • 4.3. In-Vitro Diagnostics Instrument Market, by End User, 2022 vs 2030
  • 4.4. In-Vitro Diagnostics Instrument Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising geriatric population and significant prevalence of chronic and infectious diseases
      • 5.1.1.2. Increasing adoption and availability of fully automated and POC instruments in developed regions
      • 5.1.1.3. Increased awareness about disease indication & diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Non-favourable reimbursement options
    • 5.1.3. Opportunities
      • 5.1.3.1. Targeted product development and commercialization
      • 5.1.3.2. Collaborative research and product development
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory requirements
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. In-Vitro Diagnostics Instrument Market, by Product

  • 6.1. Introduction
  • 6.2. Clinical Microbiology
  • 6.3. Hematology
  • 6.4. Hemostasis
  • 6.5. Immunochemistry
  • 6.6. Molecular Diagnostics
  • 6.7. Point-of-Care
  • 6.8. Self-Monitoring of Blood Glucose
  • 6.9. Tissue Diagnostics

7. In-Vitro Diagnostics Instrument Market, by End User

  • 7.1. Introduction
  • 7.2. Academic & Research Institutes
  • 7.3. Homecare
  • 7.4. Hospitals & Diagnostic Laboratories

8. Americas In-Vitro Diagnostics Instrument Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific In-Vitro Diagnostics Instrument Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa In-Vitro Diagnostics Instrument Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. List of Company Mentioned

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET RESEARCH PROCESS
  • FIGURE 2. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 6. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 7. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET DYNAMICS
  • FIGURE 8. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 15. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY CLINICAL MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HEMOSTASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY IMMUNOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY POINT-OF-CARE , BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY SELF-MONITORING OF BLOOD GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY TISSUE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 104. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 105. IN-VITRO DIAGNOSTICS INSTRUMENT MARKET LICENSE & PRICING